Search
for
Sort by
Research 271–300 of 1000+
- “Formulation and Evaluation of Herbal Hair Oil”
- Ayurvedic Hair Science: A Neglected Field in Need of Immediate Research Attention
- Comparing Protective Pre-treatments for African Hair
- Surgical interventions for androgenetic alopecia
- Videodermoscopy in the evaluation of hair and scalp disorders
- TRPA1 Modulates Mechanotransduction in Cutaneous Sensory Neurons
- Organogenesis From Dissociated Cells: Generation of Mature Cycling Hair Follicles From Skin-Derived Cells
- Alopecia Areata: A tissue specific autoimmune disease of the hair follicle
- Frontal fibrosing alopecia in postmenopausal women
- The Harmonies Played by TGF-β in Stem Cell Biology
- The role of scalp dermoscopy in the diagnosis of alopecia areata incognita
- Clinical manifestations of cutaneous lupus erythematosus
- Clobetasol propionate 0.05% under occlusion in the treatment of alopecia totalis/universalis
- Pathways to inflammation: acne pathophysiology
- The control of hair growth: An overview
- Erosive pustular dermatosis of the scalp: Clinical, trichoscopic, and histopathologic features of 20 cases
- A combined regimen of cyproterone acetate and testosterone enanthate as a potentially highly effective male contraceptive.
- Telogen Effluvium due to Recombinant Interferon α-2b
- Drug-Induced Hair Disorders
- DTC pharmaceutical advertising: the debate’s not over
- Alopecia and grey hair are associated with COVID‐19 Severity
- Revisiting hyper- and hypo-androgenism by tandem mass spectrometry
- Male pattern baldness and its association with coronary heart disease: a meta-analysis
- Emerging concepts about prenatal genesis, aberrant metabolism and treatment paradigms in polycystic ovary syndrome
- Testosterone therapy in men: Clinical and pharmacological perspectives
- Primary Scarring Alopecia: Clinical-Pathological Review of 72 Cases and Review of the Literature
- Alopecia in Epidermolysis Bullosa
- Erosive pustular dermatosis of the scalp: a multicentre study
- Systemic causes of hair loss
- Cutaneous adverse reactions linked to targeted anticancer therapies bortezomib and lenalidomide for multiple myeloma: new drugs, old side effects